Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
India's strategy against Covid was more effective than any other countries in the world
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Subscribe To Our Newsletter & Stay Updated
